Genmab — Marts 2018

[JKY_VH]

Ja, hvor svært kan det egentlig være:-)

[peter12]

Markedet lytter til dig

[Solsen]

Novod er ude igen med prekliniske data, der understøtter cd38/daras muligheder i colorectal cancer.

[Solsen]

JCI Insight - CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients

(insight.jci.org)

[E_L]

3rd attempt at 1287 seems to succeed, in a falling market...

[Helge_LarsenPI-redaktør]

Solsen...Se 9.49

[E_L]

Japan's Takeda considering approach for British drugmaker Shire
https://uk.reuters.com/article/us-shire-m-a-takeda-pharma/japans-takeda-considering-approach-for-british-drugmaker-shire-idUKKBN1H4198

[JStudsgaard]

Ser ud til vi bryder 200 dages glidende gennemsnit i dag...

[Nickstar]

Bulder, tak for forklaring

[henrik48]

Mon vi kommer over 1300 inden Påske

[Legolas23]

Vi lukker i 1300 flat. Spørg bare @Bibob

[Bulder]

bb2121 går i fase 3. https://seekingalpha.com/news/3342156-celgene-bluebird-bio-team-develop-commercialize-car-t-bb2121

[E_L]

i am not really sure what is new in that collaboration, you? i dont see anything about a phase 3 in the press release. But probably a firmer commitment from Celgene

[Parasitism]

Bing bing bing

[Parasitism]

1300

[Bulder]

E L, no I only have what was in the first message from seeking alpha.

[henrik48]

Kg håber at bibob forventninger bliver indfriet, så vi kan smile hele Påsken...:-)

[Helge_LarsenPI-redaktør]

Hver gang A/B træder lidt på bremsen med køb, falder kursen tilbage. Tror dog at de skal have flere i dag.

[E_L]

certainly
possible. it is month end and quarter end. wouldnt surprise me to get some volume into the close.

[E_L]

Just imagine you are a fund manager and investors note that you had no position in Genmab in your quarterly report! You will be laughed at so buy, quickly